Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Azuma

Showing results (31-40 of 339) with videos related to

Pageof 34
Sort By:
International Immunopharmacology|May 31, 2001
Comparison of the effect of lidocaine-epinephrine and prilocaine-felypressine to alter macrophage functionsY Azuma, K Ohura
Kekkaku : [Tuberculosis]|October 1, 1972
[The clinical significance of the critical drug resistance concentration of SM,INH and PAS]H Baba, Y Azuma
Canadian Journal of Microbiology|May 1, 1970
Pyocyanine degradation by apyocyanogenic strains of Pseudomonas aeruginosaY Azuma, L D Witter
Journal of Dental Research|March 1, 1975
Experimental gingivitis: development of a new strain of plaque-susceptible ratN Ito, Y Azuma, M Mori
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 23, 2000
Alteration of sugar chains on alpha(1)-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitroY Azuma, M Murata, K Matsumoto
Kekkaku : [Tuberculosis]|May 1, 1978
[Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis (preliminary report) (author's transl)]H Baba, A Shinkai, Y Azuma
Kekkaku : [Tuberculosis]|November 1, 1971
Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistanceH Baba, R Takahashi, Y Azuma
Kekkaku : [Tuberculosis]|January 1, 1979
[Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis. (Report 2)--Results at one year after completing chemotherapy--(author's transl)]H Baba, A Shinkai, Y Azuma
Neuroscience|July 30, 1999
Constitutive expression of cytoplasmic activator protein-1 with DNA binding activity and responsiveness to ionotropic glutamate signals in the murine hippocampusY Azuma, K Ogita, Y Yoneda
Nihon Jinzo Gakkai Shi|July 1, 1983
[Ureteral diseases in children, with special reference to vesico-ureteral reflux]Y Azuma, J Kawamura, O Yoshida
Pageof 34

Showing results (31-40 of 339) with videos related to

Sort By:
Pageof 34
International Immunopharmacology|May 31, 2001
Comparison of the effect of lidocaine-epinephrine and prilocaine-felypressine to alter macrophage functionsY Azuma, K Ohura
Kekkaku : [Tuberculosis]|October 1, 1972
[The clinical significance of the critical drug resistance concentration of SM,INH and PAS]H Baba, Y Azuma
Canadian Journal of Microbiology|May 1, 1970
Pyocyanine degradation by apyocyanogenic strains of Pseudomonas aeruginosaY Azuma, L D Witter
Journal of Dental Research|March 1, 1975
Experimental gingivitis: development of a new strain of plaque-susceptible ratN Ito, Y Azuma, M Mori
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 23, 2000
Alteration of sugar chains on alpha(1)-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitroY Azuma, M Murata, K Matsumoto
Kekkaku : [Tuberculosis]|May 1, 1978
[Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis (preliminary report) (author's transl)]H Baba, A Shinkai, Y Azuma
Kekkaku : [Tuberculosis]|November 1, 1971
Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistanceH Baba, R Takahashi, Y Azuma
Kekkaku : [Tuberculosis]|January 1, 1979
[Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis. (Report 2)--Results at one year after completing chemotherapy--(author's transl)]H Baba, A Shinkai, Y Azuma
Neuroscience|July 30, 1999
Constitutive expression of cytoplasmic activator protein-1 with DNA binding activity and responsiveness to ionotropic glutamate signals in the murine hippocampusY Azuma, K Ogita, Y Yoneda
Nihon Jinzo Gakkai Shi|July 1, 1983
[Ureteral diseases in children, with special reference to vesico-ureteral reflux]Y Azuma, J Kawamura, O Yoshida
Pageof 34